Kristen Ambrose
At a glance: Kristen Ambrose is Svp & Chief Accounting Officer at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Mar 2, 2026, reported a sale of $173K. On file: 0 purchase lines ($0) and 5 sale lines ($2.0M).
Disclosed holdings: about $3.5M of VRTX stock: 6,624 shares reported on their latest Form 4 (filed Mar 2, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Svp & Chief Accounting Officer at Vertex Pharmaceuticals Inc / Ma (VRTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Kristen Ambrose's InsiderPrint
5 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 5 times a year, typically $302K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (5)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Prahlad R. SinghPlease See Remarks · RVTY · 100% match
- Barry BiffleCEO · ULCC · 100% match
- Emiliano KargiemanCEO · SATL · 100% match
- Sanjay KalraCFO · PAY · 100% match
- Matthew MoschnerCEO, President · CGNX · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 2SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 3576,624 held (−5%) | $483.36 | $173K | +7.9% |
| Feb 26SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 2236,981 held (−3%) | $486.35 | $108K | +7.2% |
| Feb 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,5578,388 held (−16%) | $489.46 | $762K | +6.5% |
| Feb 19SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 6387,750 held (−8%) | $473.68 | $302K | +10.1% |
| Feb 12SEC | VRTXVertex Pharmaceuticals Inc / Ma | Sell Plan | 1,37610,127 held (−12%) | $460.43 | $634K | +13.2% |
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $173K of VRTX at $483.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $108K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $762K of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $302K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Svp & Chief Accounting Officer Kristen Ambrose sold $634K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.
Follow Kristen Ambrose
Get one email when Kristen Ambrose files a new purchase or sale. Free.
At most one email a day about Kristen Ambrose, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.